Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03174275 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03174275
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2022-02-02
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.